Summary of medicine characteristics - TCP LIQUID ANTISEPTIC
1 NAME OF THE MEDICINAL PRODUCT
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
3. PHARMACEUTICAL FORM
3. PHARMACEUTICAL FORMAqueous liquid antiseptic.
4 CLINICAL PARTICULARS
4.1 Therapeutic indications
Symptomatic relief of sore throats including those associated with colds and influenza. Common mouth ulcers, cuts, grazes, bites, stings, boils, spots and pimples.
4.2 Posology and method of administration
Adults, children and the elderly.
Symptomatic relief of sore throats including those associated with colds and flu.
Gargle twice a day with TCP diluted with 5 parts water. Do not swallow.
Common mouth ulcers.
Dab undiluted onto affected areas three times a day. If symptoms persist for more than 14 days, consult your doctor or dentist.
Cuts, grazes, bites and stings.
Dilute with an equal quantity of water and apply freely. In emergencies may be used undiluted.
Boils, spots and pimples.
Dab undiluted every 4 hours. Do not cover.
4.3 Contra-indications
Hypersensitivity to any of the active ingredients
4.4 Special warnings and precautions for use
Seek medical advice if symptoms persist for more than a few days.
Keep out of the reach and sight of children.
4.5 Interactions with other medicinal products and other forms of interaction
None known.
4.6 Pregnancy and lactation
There is no experience of the use of the product in pregnancy and lactation, but the product has been widely used for many years with no adverse effects.
4.7 Effects on ability to drive and use machines
None known.
4.8 Undesirable effects
Use in allergic skin conditions should be avoided.
4.9 Overdose
4.9 OverdoseSerious adverse events are unlikely to result from overdosage of this product.
Accidental ingestion: If a quantity (over 30ml) of neat TCP is swallowed accidentally, drink 0.5 to 1 litre of water immediately. If discomfort persists, seek medical advice.
5.1 Pharmacodynamic properties
Halogenated phenols act on all pathogenic micro-organisms similarly and to approximately the same degree – i.e. they are non-specific, their activity is not appreciably reduced by the presence of relatively large amounts of non-living organic matter, their relatively simple chemical constitution means that their use is not liable to encourage the emergence of strains of micro-organisms adapted to resist their action.
5.2 Pharmacokinetic properties
TCP Liquid Antiseptic is for topical use only. Significant absorption from this topical dosage form is considered unlikely.
5.3 Preclinical safety data
5.3 Preclinical safety dataNone stated.
6.1 List of excipients
Other ingredients: glycerol, concentrated phosphoric acid, quinoline yellow (E104) and purified water.
6.2 Incompatibilities
None known.
6.3
Shelf life
36 months.
6.4 Special precautions for storage
None.
6.5 Nature and Contents of Container
TCP Liquid Antiseptic is stored in amber flint glass bottles of 50ml, 100ml and 200ml capacity, with white wadless polypropylene tamper-evident caps, or 500ml amber flint glass bottles with white wadless polypropylene caps.
6.6 Instruction for use and handling
None stated.
7. MARKETING AUTHORISATION HOLDER
Omega Pharma Ltd.
1st Floor
32 Vauxhall Bridge Road
LONDON, SW1V 2SA
United Kingdom
8. MARKETING AUTHORISATION NUMBER
PL 02855/0021